These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 31824148)
1. Protein Encapsulation of Experimental Anticancer Agents 5F 203 and Phortress: Towards Precision Drug Delivery. Breen AF; Scurr D; Cassioli ML; Wells G; Thomas NR; Zhang J; Turyanska L; Bradshaw TD Int J Nanomedicine; 2019; 14():9525-9534. PubMed ID: 31824148 [TBL] [Abstract][Full Text] [Related]
2. Development of novel apoferritin formulations for antitumour benzothiazoles. Breen AF; Wells G; Turyanska L; Bradshaw TD Cancer Rep (Hoboken); 2019 Aug; 2(4):e1155. PubMed ID: 32721126 [TBL] [Abstract][Full Text] [Related]
3. Antitumour 2-(4-aminophenyl)benzothiazoles generate DNA adducts in sensitive tumour cells in vitro and in vivo. Leong CO; Gaskell M; Martin EA; Heydon RT; Farmer PB; Bibby MC; Cooper PA; Double JA; Bradshaw TD; Stevens MF Br J Cancer; 2003 Feb; 88(3):470-7. PubMed ID: 12569393 [TBL] [Abstract][Full Text] [Related]
4. The antitumour activity of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole in human gastric cancer models is mediated by AhR signalling. Wang Y; Liu Y; Tang T; Luo Y; Stevens MFG; Cheng X; Yang Y; Shi D; Zhang J; Bradshaw TD J Cell Mol Med; 2020 Jan; 24(2):1750-1759. PubMed ID: 31876059 [TBL] [Abstract][Full Text] [Related]
5. Bioactivation of fluorinated 2-aryl-benzothiazole antitumor molecules by human cytochrome P450s 1A1 and 2W1 and deactivation by cytochrome P450 2S1. Wang K; Guengerich FP Chem Res Toxicol; 2012 Aug; 25(8):1740-51. PubMed ID: 22734839 [TBL] [Abstract][Full Text] [Related]
6. Delivery of Temozolomide and N3-Propargyl Analog to Brain Tumors Using an Apoferritin Nanocage. Bouzinab K; Summers HS; Stevens MFG; Moody CJ; Thomas NR; Gershkovich P; Weston N; Ashford MB; Bradshaw TD; Turyanska L ACS Appl Mater Interfaces; 2020 Mar; 12(11):12609-12617. PubMed ID: 32073826 [TBL] [Abstract][Full Text] [Related]
7. CYP2S1 and CYP2W1 mediate 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW-610, NSC 721648) sensitivity in breast and colorectal cancer cells. Tan BS; Tiong KH; Muruhadas A; Randhawa N; Choo HL; Bradshaw TD; Stevens MF; Leong CO Mol Cancer Ther; 2011 Oct; 10(10):1982-92. PubMed ID: 21831963 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of acquired resistance to 2-(4-Amino-3-methylphenyl)benzothiazole in breast cancer cell lines. Bradshaw TD; Stone EL; Trapani V; Leong CO; Matthews CS; te Poele R; Stevens MF Breast Cancer Res Treat; 2008 Jul; 110(1):57-68. PubMed ID: 17674193 [TBL] [Abstract][Full Text] [Related]
9. DNA damage and cell cycle arrest induced by 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F 203, NSC 703786) is attenuated in aryl hydrocarbon receptor deficient MCF-7 cells. Trapani V; Patel V; Leong CO; Ciolino HP; Yeh GC; Hose C; Trepel JB; Stevens MF; Sausville EA; Loaiza-Pérez AI Br J Cancer; 2003 Feb; 88(4):599-605. PubMed ID: 12592376 [TBL] [Abstract][Full Text] [Related]
10. The experimental antitumor agents Phortress and doxorubicin are equiactive against human-derived breast carcinoma xenograft models. Fichtner I; Monks A; Hose C; Stevens MF; Bradshaw TD Breast Cancer Res Treat; 2004 Sep; 87(1):97-107. PubMed ID: 15377855 [TBL] [Abstract][Full Text] [Related]
11. Antitumour benzothiazoles. Part 32: DNA adducts and double strand breaks correlate with activity; synthesis of 5F203 hydrogels for local delivery. Stone EL; Citossi F; Singh R; Kaur B; Gaskell M; Farmer PB; Monks A; Hose C; Stevens MF; Leong CO; Stocks M; Kellam B; Marlow M; Bradshaw TD Bioorg Med Chem; 2015 Nov; 23(21):6891-9. PubMed ID: 26474663 [TBL] [Abstract][Full Text] [Related]
12. The development of the antitumour benzothiazole prodrug, Phortress, as a clinical candidate. Bradshaw TD; Westwell AD Curr Med Chem; 2004 Apr; 11(8):1009-21. PubMed ID: 15078163 [TBL] [Abstract][Full Text] [Related]
13. Characterization and cellular uptake of platinum anticancer drugs encapsulated in apoferritin. Xing R; Wang X; Zhang C; Zhang Y; Wang Q; Yang Z; Guo Z J Inorg Biochem; 2009 Jul; 103(7):1039-44. PubMed ID: 19501911 [TBL] [Abstract][Full Text] [Related]
14. Anti-tumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces single-strand breaks and DNA-protein cross-links in sensitive MCF-7 breast cancer cells. Brantley E; Antony S; Kohlhagen G; Meng L; Agama K; Stinson SF; Sausville EA; Pommier Y Cancer Chemother Pharmacol; 2006 Jul; 58(1):62-72. PubMed ID: 16331501 [TBL] [Abstract][Full Text] [Related]
15. Fluorinated 2-(4-amino-3-methylphenyl)benzothiazoles induce CYP1A1 expression, become metabolized, and bind to macromolecules in sensitive human cancer cells. Brantley E; Trapani V; Alley MC; Hose CD; Bradshaw TD; Stevens MF; Sausville EA; Stinson SF Drug Metab Dispos; 2004 Dec; 32(12):1392-401. PubMed ID: 15355884 [TBL] [Abstract][Full Text] [Related]
16. Aryl Hydrocarbon Receptor Ligand 5F 203 Induces Oxidative Stress That Triggers DNA Damage in Human Breast Cancer Cells. McLean LS; Watkins CN; Campbell P; Zylstra D; Rowland L; Amis LH; Scott L; Babb CE; Livingston WJ; Darwanto A; Davis WL; Senthil M; Sowers LC; Brantley E Chem Res Toxicol; 2015 May; 28(5):855-71. PubMed ID: 25781201 [TBL] [Abstract][Full Text] [Related]
17. Apoferritin encapsulation of cysteine protease inhibitors for cathepsin L inhibition in cancer cells. Quilles Junior JC; Carlos FDRR; Montanari A; Leitão A; Mignone VW; Arruda MA; Turyanska L; Bradshaw TD RSC Adv; 2019 Nov; 9(63):36699-36706. PubMed ID: 35539052 [TBL] [Abstract][Full Text] [Related]
18. New Treatments in Renal Cancer: The AhR Ligands. Itkin B; Breen A; Turyanska L; Sandes EO; Bradshaw TD; Loaiza-Perez AI Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443455 [TBL] [Abstract][Full Text] [Related]
19. In Vitro Antitumor Effects of AHR Ligands Aminoflavone (AFP 464) and Benzothiazole (5F 203) in Human Renal Carcinoma Cells. Luzzani GA; Callero MA; Kuruppu AI; Trapani V; Flumian C; Todaro L; Bradshaw TD; Loaiza Perez AI J Cell Biochem; 2017 Dec; 118(12):4526-4535. PubMed ID: 28471540 [TBL] [Abstract][Full Text] [Related]
20. 2-(4-aminophenyl) benzothiazole: a potent and selective pharmacophore with novel mechanistic action towards various tumour cell lines. Dubey R; Shrivastava PK; Basniwal PK; Bhattacharya S; Moorthy NS Mini Rev Med Chem; 2006 Jun; 6(6):633-7. PubMed ID: 16787373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]